Ibnsina Pharma (EGX:ISPH)
Egypt · Delayed Price · Currency is EGP 10.83
-0.22 (-1.99%)
At close: Dec 2, 2025
Ibnsina Pharma Revenue
Ibnsina Pharma had revenue of 20.35B EGP in the quarter ending September 30, 2025, with 30.54% growth. This brings the company's revenue in the last twelve months to 72.83B, up 50.03% year-over-year. In the year 2024, Ibnsina Pharma had annual revenue of 55.84B with 64.49% growth.
Revenue (ttm)
72.83B
Revenue Growth
+50.03%
P/S Ratio
0.15
Revenue / Employee
13.24M
Employees
5,500
Market Cap
10.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 55.84B | 21.89B | 64.49% |
| Dec 31, 2023 | 33.95B | 11.68B | 52.48% |
| Dec 31, 2022 | 22.26B | 531.66M | 2.45% |
| Dec 31, 2021 | 21.73B | 3.05B | 16.35% |
| Dec 31, 2020 | 18.68B | 2.08B | 12.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| El Sewedy Electric Company | 266.87B |
| Commercial International Bank Egypt (CIB) S.A.E. | 124.00B |
| Telecom Egypt Company | 101.94B |
| Talaat Moustafa Group Holding | 53.03B |
| Qatar National Bank | 50.63B |
| Egypt Aluminum | 43.18B |
| Eastern Company S.A.E | 37.38B |
| Misr Fertilizer Production Company | 25.16B |